Access and R&D, Nature Medicine, Canada, United States

development

Snapshot of Access and R&D

Organisations. Nature Medicine

Period. 11 - 13 May 2020

Soaring drug prices could bar access to future coronavirus treatments (Guardian)
- COVID-19 exposes drug supply gaps as Canada explores local ‘Made in Canada’ solutions (CTV News)
To deliver a COVID-19 vaccine equitably, we must start planning now (Devex)
- U.S. taxpayer funding contributed to research for a remdesivir patent that will likely remain inaccessible to many people due to the $4,500 price tag by Gilead (STAT)
Protect against market exclusivity in the fight against COVID-19 (Nature Medicine)
- Compulsory Licensing: A Cure for Distributing the Cure? (CSIS)
Mobile apps that allow real-time tracking of self-reported symptoms are effective in predicting infections, according to a new study in Nature Medicine
- COVID-19 and digital inequalities: Reciprocal impacts and mitigation strategies (Computers in Human Behavior)

This development is part of the digest;